| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 2 |
| 1 | AMLODIPINE | 1 |
| 2 | APIXABAN | 1 |
| 3 | BEVACIZUMAB | 1 |
| 4 | BIOTIN | 1 |
| 5 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 1 |
| 6 | CARBOPLATIN | 1 |
| 7 | DAPRODUSTAT | 1 |
| 8 | ERGOCALCIFEROL | 1 |
| 9 | FAMOTIDINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DAPRODUSTAT | 1 | 0.0005 |
| 1 | FARICIMAB | 1 | 0.0001 |
| 2 | TRIFLURIDINE AND TIPIRACIL | 1 | 0.0001 |
| 3 | ERGOCALCIFEROL | 1 | 0.0000 |
| 4 | BIOTIN | 1 | 0.0000 |
| 5 | LENVATINIB | 1 | 0.0000 |
| 6 | PEMETREXED DISODIUM | 1 | 0.0000 |
| 7 | PEMBROLIZUMAB | 2 | 0.0000 |
| 8 | APIXABAN | 1 | 0.0000 |
| 9 | FLUCONAZOLE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 3 | Arteriolar Vasodilator [EPC] | 1 | 0.0000 |
| 4 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |
| 5 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Azole Antifungal [EPC] | 1 | 0.0000 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 1 | 0.0000 |